Skip to content
Dark
Search
Subscribe
Follow on LinkedIn
Home
About Us
Biotech & Life Sciences
Drug Discovery
Fortune
Sustainability
Second Opinion
Press Releases
Archive
October 2025
9:
New CEO of Kindbody David Stern is in the business of building families
October 2025
7:
A Legend in the making: how Ying Huang is scaling CAR-T to global markets
October 2025
7:
From sickness to prevention: How welfare cuts risk undermining the UK's 10-Year Health Plan
October 2025
6:
Moloch and Medicine: why good intentions built a broken system, and why CGT might fix it all (sort of)
October 2025
3:
Breaking the bottleneck: why Oklo’s bet on Atomic Alchemy could change cancer care
October 2025
2:
A Bushel of Change: Digitizing the Grain Supply Chain
October 2025
2:
When is JPM Week 2026?
October 2025
1:
Engines, Excipients, and Everyday Essentials: Elizabeth Grove on Lubrizol’s Sustainability Role
September 2025
30:
One Trash Can, Infinite Possibilities: The Future of Recycling According to AMP
September 2025
30:
MassBio Statement on President Trump’s announcement on most-favored-nation pricing
September 2025
29:
Why Every Gigafactory Needs a Recycling Plant Next Door
September 2025
29:
MassBio CEO in Banker & Tradesman: Beacon Hill Must Keep Biotech’s Flywheel Turning
September 2025
29:
FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer
September 2025
27:
Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease
September 2025
26:
Finding balance in the noise
September 2025
26:
ThredUp: Scaling Second-Hand for a Sustainable Future
September 2025
25:
From Strengthening Fleets to Smart Ships: Navigating Tanker Cycles with Ardmore
September 2025
25:
Sick enough: the silent struggles of sub-clinical illness in modern medicine
September 2025
25:
In the Company of Shadows: Love, Labour, and the Long Way Through
September 2025
24:
Electricity Designed for the Future: EDF power solutions’ Tristan Grimbert on Competing in North America’s Toughest Energy Market
September 2025
24:
Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States
September 2025
23:
PowerTrack and Stem, Inc.’s Push for Renewable Confidence
September 2025
22:
Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors
September 2025
22:
Capital With Conviction: How Khosla Ventures Walks With Founders for 10x Impact
September 2025
22:
MassBio and Google empower biotech workers with AI for Drug Discovery Training
September 2025
19:
Not Just Net Zero: Why B Corp™ Must Lead the Charge on Equity and Emissions
September 2025
18:
How AI, Carbon Markets, and Co-Ops Are Changing the Economics of Farming
September 2025
18:
Launching the Palmetto Beacon Venture Fellowship: Building a stronger investor ecosystem
September 2025
18:
Gut Feelings: Harnessing the Gut Microbiome to Manage Anxiety in Primary Care
September 2025
17:
Feeding the Future: Inside Aurélio Pavinato’s Big Dream for Agriculture
September 2025
17:
Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q’s Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control
September 2025
16:
From Pistons to Powertrains: The Road Ahead for Shriram Pistons & Rings
September 2025
16:
2025 Eisai R&D Day: Deepening Connections
September 2025
15:
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
September 2025
15:
Built to Last: Why Acme Brick’s Ed Watson Believes Durability Is the Ultimate Sustainability
September 2025
15:
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
September 2025
15:
Alex M. Azar II Joins Guardant Health Board of Directors
September 2025
12:
Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease
September 2025
12:
Garbage into Gains: How RoadRunner is Using AI To Modernize Waste
September 2025
11:
Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
September 2025
11:
Learning by Saying “Yes!”: The CEO Whose Education was a Humble Startup
September 2025
11:
Guardant Health Expands Access to Shield CRC Blood Test to Senior Living Communities with LabFlorida Partnership
September 2025
10:
Avidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial in People Living with DMD44
September 2025
10:
Avidity Biosciences Announces Proposed Public Offering of Common Stock
September 2025
10:
The rise of Chinese pharmaceuticals and biotech
September 2025
10:
A Once-in-a-Century Transition: Neha Palmer on the Future of Freight Electrification
September 2025
9:
More than just a headache
September 2025
9:
Artificial intelligence in skin cancer diagnosis: Improving diagnostics and reducing health disparity
September 2025
8:
Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States
September 2025
8:
Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors
September 2025
8:
ImmunityBio’s ANKTIVA® Reverses Lymphopenia and Extends Overall Survival in Patients With Advanced Non-Small Cell Lung Cancer Resistant to Checkpoint Therapy
September 2025
8:
The Gift of Time: Apeel’s Plant-Based Coating Tackles Spoilage at Scale
September 2025
8:
Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States
September 2025
6:
Martial law targets resident physicians: implications for the healthcare crisis in South Korea
September 2025
4:
Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test
September 2025
2:
Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025
September 2025
2:
MassBio and SCbio Announce Ten Biotech and Techbio Startups to Participate in Drive Accelerator
August 2025
28:
Guardant Health to Host Investor Day on September 24, 2025
August 2025
27:
Avidity Biosciences to Participate in Upcoming Investor Conferences
August 2025
27:
Belite Bio to Participate in Three Upcoming Investor Conferences
August 2025
26:
Massachusetts Biopharma Sees Rare Job Decline Amid Funding Constraints and Federal Uncertainty
August 2025
26:
Initial Data Shows 100% Disease Control in 5 Out of 5 Patients With Recurrent Glioblastoma With Two Patients in Near Complete Response Treated With ImmunityBio’s ANKTIVA®, NK Cell Therapy Plus Optune Gio® Device
August 2025
26:
Guardant Health to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
August 2025
25:
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
August 2025
21:
From Flares to Fuel: Verde Clean Fuels’ Plan to Clean Up Gasoline
August 2025
20:
Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder’s Ownership Following Administrative Change to 13D Filing
August 2025
19:
ImmunityBio Announces Phase 2 Study of ANKTIVA® in Patients with Long COVID
August 2025
18:
TerraCycle: Turning the 95% of Waste that No One Wants into a Global Business
August 2025
18:
Concrete Economics: Why Fortera’s Cement Is Built to Scale
August 2025
15:
No Trade-Offs, No Excuses: Natel Energy’s Fish-Friendly Turbines
August 2025
15:
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 2025
13:
Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST—Modifier Gene Therapy for Stargardt Disease
August 2025
13:
ImmunityBio Reports Complete Responses in Non-Hodgkin Waldenstrom Lymphoma Patients with Chemotherapy-Free, First-In-Class CD19 CAR-NK Immunotherapy
August 2025
12:
Flying Clean & Flying Safe: Talking Electric Air Travel with Eve Air Mobility’s Johann Bordais
August 2025
12:
Plug and Pray No More: How Fastned Is Driving Europe’s EV Future
August 2025
12:
Ocugen, Inc. Announces Closing of $20 Million Registered Direct Offering of Common Stock and Warrants
August 2025
11:
Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
August 2025
11:
ImmunityBio Announces Houston’s Michael E. DeBakey VA Medical Center Is Among the First VA Hospitals to Administer ANKTIVA® to Bladder Cancer Patients
August 2025
8:
Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants
August 2025
7:
Belite Bio Announces Registered Direct Offering of $15 Million
August 2025
7:
Phathom Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 2025
4:
American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity
July 2025
28:
Why Electrovaya isn’t chasing cars - and why that’s a smart bet
July 2025
25:
Solar, Storage and Staking: Richard Lu’s Plan to Keep the Lights On in a Digital World
July 2025
11:
How Eztia is Taking the Heat off: Tiffany Yeh on Sustainability, Worker Safety, and Customer-Led Innovation
July 2025
4:
Milliseconds Matter: How Wärtsilä’s Battery Tech Is Reinventing Grid Reliability
June 2025
26:
Verily Continues Partnership with Vanderbilt University Medical Center to Support Next Generation of NIH All of Us Researcher Workbench
June 2025
20:
Is COP a flop?
June 2025
17:
Wasted Potential: Rethinking Sustainability in Healthcare
June 2025
12:
Quenching Global Demand: How Nerovate Is Using AI and Lean Principles to Revolutionize Water Management
May 2025
30:
What if you could simply pull carbon out of the atmosphere?
May 2025
22:
Hydro-Québec's energy storage spin-out EVLO might be key to a more reliable grid
May 2025
11:
Onyx @ Union Square: Shankar Musunuri, Ocugen
May 2025
7:
CAR T-cell therapies are expensive and unsustainable - Cytiva are trying to change that
April 2025
30:
Verily awarded research grant from The Michael J. Fox Foundation to generate one of the world’s largest, high-dimensional molecular datasets of Parkinson’s patients
April 2025
27:
How Pope Francis shaped the Church’s response to climate change and sustainability
April 2025
22:
Could compressed air be the key to sustainable energy storage?
April 2025
17:
Verily welcomes new organizations who will use Workbench to manage large biomedical datasets and accelerate research
April 2025
11:
How Puro.earth became the first public registry dedicated to carbon removal
April 2025
9:
Onyx @ Union Square: Mike Exton, Lexicon Pharmaceuticals
April 2025
5:
The future of fluorescence is smaller, smarter, and more accessible
March 2025
31:
Onyx Studio Sessions: Paula Brown Stafford, Allucent
March 2025
30:
Could Trump’s tariffs prove good for the environment?
March 2025
28:
Onyx @ Union Square: Colleen Cutcliffe, Pendulum
March 2025
24:
"It's like Duolingo for sewing" - how Della Yellow is ushering in the age of circular fashion
March 2025
24:
Microplastics: A Hidden Peril for the Arctic
March 2025
24:
How Piramal Pharma plans to become a multi-billion dollar business
March 2025
20:
We all want our hospital records in one place. Is Novellia the app to do it?
March 2025
15:
Adil's JPM Week VLOG
March 2025
14:
Onyx Studio Sessions: Fabian Gerlinghaus, Cellares
March 2025
13:
Backed by AstraZeneca, this company is helping radioligand cancer therapies hit the shelves
March 2025
4:
Onyx @ Union Square: Helmy Eltoukhy, Guardant Health
February 2025
20:
CAR-T can only treat 3% of cancer patients. Mongoose Bio is building for the other 97%
February 2025
11:
This biotech is targeting the 'immortality switch' to fight blood cancers
February 2025
5:
NVIDIA’s Biggest Bet Yet: How Recursion Is Powering a New Era of AI-Driven Drug Discovery
January 2025
31:
From Grammys to Gene Therapy: Gaurav Shah’s Rocket-Fueled Revolution in Rare Diseases
January 2025
9:
Is neuromodulation the breakthrough that Alzheimer's has been waiting for?
January 2025
7:
Mayo Clinic-backed, Halle Berry-approved: Pendulum’s Dr. Colleen Cutcliffe is tackling type 2 diabetes before it even starts.
January 2025
6:
From paper to pancreas: how Aspect Biosystems is leading a bioprinting revolution
January 2025
2:
Could a single pill crack the code of treating Alzheimer's disease?
December 2024
24:
enGene injects new hope into the future of bladder cancer care
December 2024
22:
Top Satellite Events at JPM Week
December 2024
20:
How Saama’s ‘Clinical-LM’ is Supercharging Global Drug Trials
December 2024
20:
A CRO for biotechs to grow
December 2024
6:
Is a world without eyedrops possible?
December 2024
5:
Blood tests for cancer are here and Guardant Health is leading the charge
December 2024
5:
GERD affects millions of Americans. This drug is the first major innovation in three decades.
December 2024
4:
Let there Belite: an oral pill for vision loss
December 2024
3:
How ImmunityBio is transforming cancer treatment - in just 30 seconds
December 2024
3:
Ocugen has a cure in sight
December 2024
2:
Gene therapy in ophthalmology is on the cusp of a breakthrough
December 2024
1:
Vital Signs: Future of Healthcare
November 2024
27:
CAR T-cell therapies beat blood cancer - can they do the same for autoimmune diseases?
November 2024
25:
How Seer is using proteomics to revolutionize how we understand complex diseases
November 2024
22:
This biotech is using the chromatin regulatory system to fight back against cancer
November 2024
22:
Cell therapy used to be expensive, then Cellares changed everything
November 2024
20:
Alphabet's Verily is the future of precision and public health
November 2024
20:
A deep dive into one of the fastest growing biotechs of all time
November 2024
18:
Inside the world’s most innovative square mile: MassBio leads the life sciences
November 2024
18:
How rationally designed therapeutics could revolutionize gene therapy
October 2024
8:
This new blood test could change everything for immunocompromised patients
October 2024
7:
What a 10 year mission to become a leading CRO looks like
October 2024
7:
This startup could save big pharma millions of dollars using a new AI translatability platform
September 2024
30:
How big could the GLP-1 activator market be?
September 2024
24:
Opentrons, backed by SoftBank & Khosla, is bringing lab automation to the masses
September 2024
24:
New CEO Dr. Mike Exton has big plans for Lexicon Pharma in 2025
September 2024
22:
Do no harm in the age of gene editing
September 2024
10:
What are GLP-1 agonists and how valuable are they?
September 2024
6:
The 3 Biggest Biotech Events in 2025
September 2024
2:
Blood Diagnostics: 3 Biotechs to Watch
August 2024
27:
A New Age in Medicine: The Potential of Cell and Gene Therapy
